RT Book, Section
A1 Ramineni, Maheshwari
A1 Chirieac, Lucian R.
A1 Wheeler, Thomas M.
A1 Wolf, Andrea S.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Burt, Bryan M.
A2 Groth, Shawn S.
A2 Loor, Gabriel
A2 Wolf, Andrea S.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1170409864
T1 Role of Pathology in Treatment of Lung Cancer
T2 Sugarbaker’s Adult Chest Surgery, 3e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260026931
LK accesssurgery.mhmedical.com/content.aspx?aid=1170409864
RD 2024/09/10
AB A  pathologist  experienced  in  thoracic  oncology  is  an  essential  member  of  the  thoracic  team.  The  pathologist  plays  a  fundamental  role  in  the  preoperative,  intraoperative,  and  postoperative  diagnostic  and  staging  evaluation  of  the  tissue  specimens.  Traditionally,  the  surgical  pathologist’s  role  was  confined  to  diagnostic  and  staging  evaluation.  However,  with  the  advent  of  new  innovations  in  molecular  methodologies  and  precision  medicine,  they  now  play  a  pivotal  role  in  the  provision  of  prognostic  and  predictive  biomarker  data  for  targeted  therapies.  Thus,  there  has  been  a  paradigm  shift  in  the  role  of  the  pathologist,  and  the  scope  of  their  duties  has  broadened  considerably.  Yet,  for  the  foreseeable  future,  their  traditional  expertise  will  remain  an  important  component  of  precision  medicine.1  The  goal  of  tissue  examination  varies  depending  on  the  clinical  setting.  In  the  preoperative  and  intraoperative  settings,  the  pathologist  is  mainly  focused  on  accurate  diagnosis  and  molecular  profiling,  whereas,  in  the  postoperative  setting,  the  focus  shifts  to  staging.